Sickle Cell Anemia Treatment in India
Sickle cell anemia treatment in India offers a range of effective options, including medication, blood transfusions, and, in some cases, stem cell or bone marrow transplants. The cost for treatment varies depending on the type and severity of the condition. On average, medical management and regular blood transfusions can range from $20,000 to $40,000 USD.
India’s advanced healthcare facilities provide high-quality care at a significantly lower cost compared to Western countries. This affordability, coupled with skilled medical professionals and comprehensive treatment plans, makes India a viable option for those seeking effective management of sickle cell anemia.
Cost of Sickle Cell Anemia Treatment in India
Minimum Cost
USD 20000
Maximum Cost
USD 40000
Total Stay
90 Days
Hospital Stay
21 Days
Get Cost Estimate
Process of Sickle Cell Anemia Treatment in India
SHARE YOUR CONTACT DETAILS
RECEIVE COST ESTIMATE IN 48 HOURS
GET RECEIVED BY OUR TEAM
GET TREATED AND FLY BACK
Inclusion & Exclusion of the Treatment
Inclusion of the Treatment
- Medication and Therapy
- Blood Transfusions
- Stem Cell or Bone Marrow Transplant
- Diagnostic Tests and Monitoring
- Hospital Services and Care
Exclusion of the Treatment
- Pre-Treatment Medications
- Additional Alternative Therapies
- Travel and Accommodation Costs
- Long-Term Maintenance Beyond Initial Care
- Insurance Coverage and Financial Assistance
Factors Affecting the Cost of Sickle Cell Anemia Treatment in India
- Type of Treatment: Costs vary based on whether treatment includes medication, blood transfusions, or advanced options like stem cell or bone marrow transplants.
- Severity of the Condition: The complexity and severity of the sickle cell anemia can impact treatment duration and cost.
- Healthcare Facility: Charges differ between hospitals and clinics based on their facilities, location, and reputation.
- Frequency of Treatment: Regular treatments, such as frequent blood transfusions or ongoing medication, affect overall expenses.
- Doctor's Expertise: Fees for experienced hematologists and specialists can influence treatment costs.
- Diagnostic Tests: Additional tests and monitoring required to manage and assess the condition contribute to the total cost.
Types of Sickle Cell Anemia Treatment in India
Treatment options for sickle cell anemia in India include medication, blood transfusions, and advanced therapies like stem cell or bone marrow transplants.
Types of Sickle Cell Anemia Treatment in India | Cost in USD |
|---|---|
Medication (per year) | $500 – $1,500 |
Regular Blood Transfusions (per year) | $2,000 – $5,000 |
Stem Cell or Bone Marrow Transplant | $20,000 – $40,000 |
Hydroxyurea Therapy (per year) | $1,000 – $2,500 |
Top Sickle Cell Anemia Treatment Hospitals in India
Top Sickle Cell Anemia Treatment Doctors in India
Principal Director & Chief Hematology | Fortis Noida
Vice Chairman - Haemato Oncology & BMT
Consultant - Medical Oncology, Haematology and Bone Marrow Transplant
Principal Director & Paediatric Hematology | Fortis Noida
Dr. Rahul Bhargava
Principal Director and Chief of Hematology | Fortis Noida
Dr. Dharma Choudhary
Vice Chairman - Haemato Oncology & BMT
Dr. Gaurav Dixit
Unit Head - Haemato
Oncology
Dr. Vikas Dua
Principal Director of Paediatric Hematology | Fortis Noida
Get Cost Estimate
Why Choose Medserg for Sickle Cell Anemia Treatment in India?
- Expert Medical Team: Medserg partners with experienced hematologists and specialists who provide advanced and personalized care for sickle cell anemia.
- Comprehensive Treatment Options: Medserg offers a full range of treatment options, including medication, blood transfusions, and stem cell transplants, tailored to each patient’s needs.
- State-of-the-Art Facilities: Equipped with the latest technology and diagnostic tools, Medserg ensures high-quality care and effective treatment outcomes.
- Affordable Pricing: Medserg provides transparent and competitive pricing, making advanced sickle cell anemia treatments more accessible without compromising on quality.
- Patient-Centric Support: Medserg offers comprehensive support services, including patient counseling, follow-up care, and assistance with travel and accommodation for international patients.
Diagnostic Tests for Sickle Cell Anemia Treatment in India
Diagnostic tests for sickle cell anemia in India typically include blood tests, hemoglobin electrophoresis, and genetic screening to confirm the diagnosis and assess the severity.
Types of Tests For Sickle Cell Anemia Treatment in India | Cost Range in USD |
|---|---|
Complete Blood Count (CBC) | $20 – $50 |
Hemoglobin Electrophoresis | $50 – $150 |
Sickle Cell Test | $30 – $100 |
Genetic Screening | $100 – $300 |
Tests Before Sickle Cell Anemia Treatment in India
Before starting sickle cell anemia treatment in India, essential tests include blood tests, hemoglobin electrophoresis, and genetic screening to evaluate the condition and determine the appropriate treatment plan.
Bone Marrow Aspiration
Examines bone marrow to evaluate blood cell production and rule out other conditions affecting blood cells.
Reticulocyte Count
Measures the number of immature red blood cells to evaluate the bone marrow’s response to anemia
Sickle Cell Test
Detects the presence of sickle-shaped red blood cells and confirms the diagnosis of sickle cell anemia
Genetic Screening
Analyzes DNA to identify specific genetic mutations responsible for sickle cell anemia and assess inheritance patterns.
Methods for Sickle Cell Anemia Treatment in India with Medserg
Customized Treatment Plans: Medserg designs individualized treatment plans, combining medications, blood transfusions, and advanced therapies tailored to the patient’s specific condition and needs.
Advanced Therapies: Medserg provides access to state-of-the-art treatments such as hydroxyurea therapy and stem cell or bone marrow transplants, aimed at improving outcomes and managing symptoms.
Comprehensive Care: Medserg offers a holistic approach with ongoing monitoring, patient education, and supportive care services, ensuring thorough management of sickle cell anemia throughout the treatment process.